Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
15.09
+0.20 (1.34%)
Jun 24, 2025, 4:00 PM - Market closed
Select Medical Holdings Stock Forecast
Stock Price Forecast
The 4 analysts that cover Select Medical Holdings stock have a consensus rating of "Buy" and an average price target of $27.33, which forecasts a 81.11% increase in the stock price over the next year. The lowest target is $19 and the highest is $42.
Price Target: $27.33 (+81.11%)
Analyst Consensus: Buy
* Price targets were last updated on May 7, 2025.
Analyst Ratings
The average analyst rating for Select Medical Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $23 → $19 | Buy | Maintains | $23 → $19 | +25.91% | May 7, 2025 |
RBC Capital | RBC Capital | Buy Maintains $47 → $23 | Buy | Maintains | $47 → $23 | +52.42% | Feb 24, 2025 |
UBS | UBS | Hold Maintains $40 → $21 | Hold | Maintains | $40 → $21 | +39.17% | Jan 3, 2025 |
Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 25, 2024 |
RBC Capital | RBC Capital | Buy Maintains $40 → $47 | Buy | Maintains | $40 → $47 | +211.46% | Nov 4, 2024 |
Financial Forecast
Revenue This Year
5.46B
from 5.19B
Increased by 5.26%
Revenue Next Year
5.76B
from 5.46B
Increased by 5.48%
EPS This Year
1.11
from 1.70
Decreased by -34.41%
EPS Next Year
1.35
from 1.11
Increased by 21.45%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 5.7B | 6.0B | 6.4B |
Avg | 5.5B | 5.8B | 6.0B |
Low | 5.3B | 5.5B | 5.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 10.6% | 10.8% | 10.5% |
Avg | 5.3% | 5.5% | 4.9% |
Low | 1.3% | 1.0% | -0.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1.20 | 1.66 | 1.97 |
Avg | 1.11 | 1.35 | 1.58 |
Low | 1.04 | 1.18 | 1.37 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | -29.5% | 48.9% | 45.9% |
Avg | -34.4% | 21.5% | 16.9% |
Low | -38.9% | 5.5% | 1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.